203 related articles for article (PubMed ID: 21237216)
1. The role of DDX3 in regulating Snail.
Sun M; Song L; Zhou T; Gillespie GY; Jope RS
Biochim Biophys Acta; 2011 Mar; 1813(3):438-47. PubMed ID: 21237216
[TBL] [Abstract][Full Text] [Related]
2. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
3. DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.
Sun M; Zhou T; Jonasch E; Jope RS
Biochim Biophys Acta; 2013 Jun; 1833(6):1489-97. PubMed ID: 23470959
[TBL] [Abstract][Full Text] [Related]
4. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
5. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway.
Shen L; Zhang J; Xu M; Zheng Y; Wang M; Yang S; Qin B; Li S; Dong L; Dai F
Int J Biol Sci; 2022; 18(10):3918-3933. PubMed ID: 35844798
[No Abstract] [Full Text] [Related]
6. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
7. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
8. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
9. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
10. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
11. A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.
Zhang H; Zhang Y; Chen C; Zhu X; Zhang C; Xia Y; Zhao Y; Andrisani OM; Kong L
Cancer Lett; 2018 Nov; 437():67-78. PubMed ID: 30165191
[TBL] [Abstract][Full Text] [Related]
12. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
[TBL] [Abstract][Full Text] [Related]
13.
Yang F; Fang E; Mei H; Chen Y; Li H; Li D; Song H; Wang J; Hong M; Xiao W; Wang X; Huang K; Zheng L; Tong Q
Cancer Res; 2019 Feb; 79(3):557-571. PubMed ID: 30563889
[TBL] [Abstract][Full Text] [Related]
14. Rottlerin upregulates DDX3 expression in hepatocellular carcinoma.
Wang Z; Shen GH; Xie JM; Li B; Gao QG
Biochem Biophys Res Commun; 2018 Jan; 495(1):1503-1509. PubMed ID: 29203243
[TBL] [Abstract][Full Text] [Related]
15. DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
Wu DW; Lin PL; Cheng YW; Huang CC; Wang L; Lee H
Oncotarget; 2016 Apr; 7(16):22687-99. PubMed ID: 27007150
[TBL] [Abstract][Full Text] [Related]
16. Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.
Vellky JE; Ricke EA; Huang W; Ricke WA
Am J Pathol; 2019 Jun; 189(6):1256-1267. PubMed ID: 30926334
[TBL] [Abstract][Full Text] [Related]
17. [Role of up-regulated DDX3 in the proliferation of human cervical cancer cells].
Guo FF; Zhao RJ; Li DJ; Xu ZG; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):119-124. PubMed ID: 33535306
[No Abstract] [Full Text] [Related]
18. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.
Doneti R; Pasha A; Botlagunta M; Heena SK; Mutyala VVVP; Pawar SC
Med Oncol; 2022 Sep; 39(11):179. PubMed ID: 36048256
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-196a promotes cell proliferation and inhibits apoptosis in human ovarian cancer by directly targeting DDX3 and regulating the PTEN/PI3K/AKT signaling pathway.
Ni J; Chen L; Ling L; Wu M; Ren Q; Zhu W
Mol Med Rep; 2020 Aug; 22(2):1277-1284. PubMed ID: 32626994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]